203 related articles for article (PubMed ID: 25511260)
41. Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside-induced nephrosis by suppressing inflammation and apoptosis.
Wen Y; Zhan Y; Liu H; Zhao T; Yang L; Zhang H; Dong X; Li P
BMC Complement Altern Med; 2015 May; 15():155. PubMed ID: 26014479
[TBL] [Abstract][Full Text] [Related]
42. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
[TBL] [Abstract][Full Text] [Related]
43. Antioxidant and anti-fatigue activities of flavonoids from Puerariae radix.
Xiaoming W; Ling L; Jinghang Z
Afr J Tradit Complement Altern Med; 2012; 9(2):221-7. PubMed ID: 23983338
[TBL] [Abstract][Full Text] [Related]
44. TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer Patients.
Xin DS; Zhou L; Li CZ; Zhang SQ; Huang HQ; Qiu GD; Lin LF; She YQ; Zheng JT; Chen C; Fang L; Chen ZS; Zhang SY
Recent Pat Anticancer Drug Discov; 2018; 13(3):341-347. PubMed ID: 29512471
[TBL] [Abstract][Full Text] [Related]
45. Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer.
Demečková V; Solár P; Hrčková G; Mudroňová D; Bojková B; Kassayová M; Gancarčiková S
Biomed Pharmacother; 2017 May; 89():245-256. PubMed ID: 28235687
[TBL] [Abstract][Full Text] [Related]
46. Effect of zymosan on antioxidant and immune function of S180 tumor-bearing mice.
Liu XL; Lin N; Zan D; Yuan JJ; Cai DL
Cell Biochem Biophys; 2011 Jul; 60(3):225-9. PubMed ID: 21279551
[TBL] [Abstract][Full Text] [Related]
47. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
[TBL] [Abstract][Full Text] [Related]
48. Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
Takashima T; Kawajiri H; Nishimori T; Tei S; Nishimura S; Yamagata S; Tokunaga S; Mizuyama Y; Sunami T; Tezuka K; Ikeda K; Ogawa Y; Kashiwagi S; Noda S; Onoda N; Ishikawa T; Kudoh S; Takada M; Hirakawa K; Ohira M
Anticancer Res; 2018 Jan; 38(1):379-383. PubMed ID: 29277798
[TBL] [Abstract][Full Text] [Related]
49. Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel.
Martinelli M; Bonezzi K; Riccardi E; Kuhn E; Frapolli R; Zucchetti M; Ryan AJ; Taraboletti G; Giavazzi R
Br J Cancer; 2007 Oct; 97(7):888-94. PubMed ID: 17848949
[TBL] [Abstract][Full Text] [Related]
50. [Research on mechanism of Tougu Xiaotong Granule in preventing and treating knee osteoarthritis].
Liu XX; Li XH; Zhou JT
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jan; 27(1):50-4. PubMed ID: 17302065
[TBL] [Abstract][Full Text] [Related]
51. Immunomodulation of Bu-Zhong-Yi-Qi-Tang on in vitro granulocyte colony-stimulating-factor and tumor necrosis factor-alpha production by peripheral blood mononuclear cells.
Kao ST; Yang SL; Hsieh CC; Yang MD; Wang TF; Lin JG
Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):711-20. PubMed ID: 11105783
[TBL] [Abstract][Full Text] [Related]
52. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
53. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
[TBL] [Abstract][Full Text] [Related]
54. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
Pawar VK; Panchal SB; Singh Y; Meher JG; Sharma K; Singh P; Bora HK; Singh A; Datta D; Chourasia MK
J Control Release; 2014 Dec; 196():295-306. PubMed ID: 25459427
[TBL] [Abstract][Full Text] [Related]
55. Effects of the Chinese Yi-Qi-Bu-Shen Recipe extract on brainstem auditory evoked potential in rats with diabetes.
Liu DS; Gao W; Lin WW; Hao YY; Zhong LH; Li W; Inoguchi T; Takayanagi R
J Ethnopharmacol; 2011 Sep; 137(1):414-20. PubMed ID: 21669272
[TBL] [Abstract][Full Text] [Related]
56. iTRAQ-Based Proteomics Analysis of Plasma of Myasthenia Gravis Patients Treated with Jia Wei Bu Zhong Yi Qi Decoction.
Zhang Y; Yang J; Chen Y; Lv J; Zhang J; Zhang Y; Zhao X; Fang H; Liu C; Zhang Q; Cui X; Wang X; Gao F
Evid Based Complement Alternat Med; 2019; 2019():9147072. PubMed ID: 31915455
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous determination of multiple bioactive components of Bu-zhong-yi-qi-tang in rat tissues by LC-MS/MS: Application to a tissue distribution study.
He M; Chen W; Wang M; Wu Y; Zeng J; Zhang Z; Shen S; Jiang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():177-184. PubMed ID: 28113140
[TBL] [Abstract][Full Text] [Related]
58. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy.
Shan L; Cui S; Du C; Wan S; Qian Z; Achilefu S; Gu Y
Biomaterials; 2012 Jan; 33(1):146-62. PubMed ID: 21959006
[TBL] [Abstract][Full Text] [Related]
59. A proprietary herbal drug Young Yum Pill ameliorates chronic fatigue syndrome in mice.
Yin C; Fu X; Chou J; Li J; Chen Y; Bai J; Wu J; Wu Y; Wang X; Yu ZL
Phytomedicine; 2021 Jul; 88():153602. PubMed ID: 34102522
[TBL] [Abstract][Full Text] [Related]
60. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
